The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. Acromegalyusually affects middle-aged adults.
The global Acromegaly market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Acromegaly, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acromegaly.
Report Scope
The Acromegaly market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acromegaly market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acromegaly companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Aegis Therapeutics
Chiasma
Crinetics Pharmaceuticals
Daewoong Pharmaceutical
Peptron
Silence Therapeutics
Strongbridge Biopharma
Amryt Pharma
Foresee Pharmaceuticals
Glide Pharmaceutical
Ionis Pharmaceuticals
Ipsen
Segment by Type
Somatostatin Analogues
Dopamine Agonists
Growth Hormone Receptor Antagonists
Other
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acromegaly companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. Acromegalyusually affects middle-aged adults.
The global Acromegaly market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Acromegaly, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acromegaly.
Report Scope
The Acromegaly market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acromegaly market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Acromegaly companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Aegis Therapeutics
Chiasma
Crinetics Pharmaceuticals
Daewoong Pharmaceutical
Peptron
Silence Therapeutics
Strongbridge Biopharma
Amryt Pharma
Foresee Pharmaceuticals
Glide Pharmaceutical
Ionis Pharmaceuticals
Ipsen
Segment by Type
Somatostatin Analogues
Dopamine Agonists
Growth Hormone Receptor Antagonists
Other
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acromegaly companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acromegaly Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Somatostatin Analogues
1.2.3 Dopamine Agonists
1.2.4 Growth Hormone Receptor Antagonists
1.2.5 Other
1.3 Market by Application
1.3.1 Global Acromegaly Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acromegaly Market Perspective (2019-2030)
2.2 Acromegaly Growth Trends by Region
2.2.1 Global Acromegaly Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Acromegaly Historic Market Size by Region (2019-2024)
2.2.3 Acromegaly Forecasted Market Size by Region (2025-2030)
2.3 Acromegaly Market Dynamics
2.3.1 Acromegaly Industry Trends
2.3.2 Acromegaly Market Drivers
2.3.3 Acromegaly Market Challenges
2.3.4 Acromegaly Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acromegaly Players by Revenue
3.1.1 Global Top Acromegaly Players by Revenue (2019-2024)
3.1.2 Global Acromegaly Revenue Market Share by Players (2019-2024)
3.2 Global Acromegaly Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acromegaly Revenue
3.4 Global Acromegaly Market Concentration Ratio
3.4.1 Global Acromegaly Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acromegaly Revenue in 2023
3.5 Acromegaly Key Players Head office and Area Served
3.6 Key Players Acromegaly Product Solution and Service
3.7 Date of Enter into Acromegaly Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acromegaly Breakdown Data by Type
4.1 Global Acromegaly Historic Market Size by Type (2019-2024)
4.2 Global Acromegaly Forecasted Market Size by Type (2025-2030)
5 Acromegaly Breakdown Data by Application
5.1 Global Acromegaly Historic Market Size by Application (2019-2024)
5.2 Global Acromegaly Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Acromegaly Market Size (2019-2030)
6.2 North America Acromegaly Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Acromegaly Market Size by Country (2019-2024)
6.4 North America Acromegaly Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acromegaly Market Size (2019-2030)
7.2 Europe Acromegaly Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Acromegaly Market Size by Country (2019-2024)
7.4 Europe Acromegaly Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acromegaly Market Size (2019-2030)
8.2 Asia-Pacific Acromegaly Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Acromegaly Market Size by Region (2019-2024)
8.4 Asia-Pacific Acromegaly Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acromegaly Market Size (2019-2030)
9.2 Latin America Acromegaly Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Acromegaly Market Size by Country (2019-2024)
9.4 Latin America Acromegaly Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acromegaly Market Size (2019-2030)
10.2 Middle East & Africa Acromegaly Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Acromegaly Market Size by Country (2019-2024)
10.4 Middle East & Africa Acromegaly Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Acromegaly Introduction
11.1.4 Novartis Revenue in Acromegaly Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Aegis Therapeutics
11.2.1 Aegis Therapeutics Company Detail
11.2.2 Aegis Therapeutics Business Overview
11.2.3 Aegis Therapeutics Acromegaly Introduction
11.2.4 Aegis Therapeutics Revenue in Acromegaly Business (2019-2024)
11.2.5 Aegis Therapeutics Recent Development
11.3 Chiasma
11.3.1 Chiasma Company Detail
11.3.2 Chiasma Business Overview
11.3.3 Chiasma Acromegaly Introduction
11.3.4 Chiasma Revenue in Acromegaly Business (2019-2024)
11.3.5 Chiasma Recent Development
11.4 Crinetics Pharmaceuticals
11.4.1 Crinetics Pharmaceuticals Company Detail
11.4.2 Crinetics Pharmaceuticals Business Overview
11.4.3 Crinetics Pharmaceuticals Acromegaly Introduction
11.4.4 Crinetics Pharmaceuticals Revenue in Acromegaly Business (2019-2024)
11.4.5 Crinetics Pharmaceuticals Recent Development
11.5 Daewoong Pharmaceutical
11.5.1 Daewoong Pharmaceutical Company Detail
11.5.2 Daewoong Pharmaceutical Business Overview
11.5.3 Daewoong Pharmaceutical Acromegaly Introduction
11.5.4 Daewoong Pharmaceutical Revenue in Acromegaly Business (2019-2024)
11.5.5 Daewoong Pharmaceutical Recent Development
11.6 Peptron
11.6.1 Peptron Company Detail
11.6.2 Peptron Business Overview
11.6.3 Peptron Acromegaly Introduction
11.6.4 Peptron Revenue in Acromegaly Business (2019-2024)
11.6.5 Peptron Recent Development
11.7 Silence Therapeutics
11.7.1 Silence Therapeutics Company Detail
11.7.2 Silence Therapeutics Business Overview
11.7.3 Silence Therapeutics Acromegaly Introduction
11.7.4 Silence Therapeutics Revenue in Acromegaly Business (2019-2024)
11.7.5 Silence Therapeutics Recent Development
11.8 Strongbridge Biopharma
11.8.1 Strongbridge Biopharma Company Detail
11.8.2 Strongbridge Biopharma Business Overview
11.8.3 Strongbridge Biopharma Acromegaly Introduction
11.8.4 Strongbridge Biopharma Revenue in Acromegaly Business (2019-2024)
11.8.5 Strongbridge Biopharma Recent Development
11.9 Amryt Pharma
11.9.1 Amryt Pharma Company Detail
11.9.2 Amryt Pharma Business Overview
11.9.3 Amryt Pharma Acromegaly Introduction
11.9.4 Amryt Pharma Revenue in Acromegaly Business (2019-2024)
11.9.5 Amryt Pharma Recent Development
11.10 Foresee Pharmaceuticals
11.10.1 Foresee Pharmaceuticals Company Detail
11.10.2 Foresee Pharmaceuticals Business Overview
11.10.3 Foresee Pharmaceuticals Acromegaly Introduction
11.10.4 Foresee Pharmaceuticals Revenue in Acromegaly Business (2019-2024)
11.10.5 Foresee Pharmaceuticals Recent Development
11.11 Glide Pharmaceutical
11.11.1 Glide Pharmaceutical Company Detail
11.11.2 Glide Pharmaceutical Business Overview
11.11.3 Glide Pharmaceutical Acromegaly Introduction
11.11.4 Glide Pharmaceutical Revenue in Acromegaly Business (2019-2024)
11.11.5 Glide Pharmaceutical Recent Development
11.12 Ionis Pharmaceuticals
11.12.1 Ionis Pharmaceuticals Company Detail
11.12.2 Ionis Pharmaceuticals Business Overview
11.12.3 Ionis Pharmaceuticals Acromegaly Introduction
11.12.4 Ionis Pharmaceuticals Revenue in Acromegaly Business (2019-2024)
11.12.5 Ionis Pharmaceuticals Recent Development
11.13 Ipsen
11.13.1 Ipsen Company Detail
11.13.2 Ipsen Business Overview
11.13.3 Ipsen Acromegaly Introduction
11.13.4 Ipsen Revenue in Acromegaly Business (2019-2024)
11.13.5 Ipsen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
